GlassScriptPrepare for your visit
Ojas Patel
Allergy & Immunology · Austin, TX · NPI 1205973583
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$22,634.16
in general payments reported to CMS, 2019-2025 · $1,265 in 2025
The $1,265 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $8,800.61
- Novartis Pharmaceuticals Corporation $7,909.46
- Genentech USA, INC. $1,763.37
- Takeda Pharmaceuticals U.S.A., INC. $829.37
- Glaxosmithkline, LLC. $663.67
- Genzyme Corporation $557.70
Drugs and devices associated with these payments
Fasenra Dupixent Cuvitru Hyqvia Xolair Hizentra Ayvakit Airsupra Trelegy Ellipta Cutaquig Neffy Oralair
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ojas Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/9435/ojas-patel